Non-lesional white matter changes in pediatric multiple sclerosis and monophasic demyelinating disorders

J M Tillema1, J Leach, I Pirko

  • 1Department of Neurology, Mayo Clinic, Minnesota 55905, USA. tillema.janmendelt@mayo.edu

Multiple Sclerosis (Houndmills, Basingstoke, England)
|May 30, 2012
PubMed
Abstract

Insights

Diffusion tensor imaging (DTI) reveals white matter changes in pediatric multiple sclerosis (MS) and monophasic demyelinating illnesses. Reduced axial diffusivity (AD) in normal-appearing white matter (NAWM) may distinguish pediatric MS.

Area of Science:

  • Neuroimaging
  • Neurology
  • Pediatric Neurology

Background:

  • Monophasic demyelinating illnesses are difficult to distinguish from MS using standard MRI.
  • Diffusion tensor imaging (DTI) studies in adults suggest normal-appearing white matter (NAWM) is affected in MS.

Purpose of the Study:

  • To compare DTI-derived metrics in children with MS, monophasic demyelinating illnesses, and healthy controls.
  • To investigate potential DTI biomarkers for early demyelinating events in children.

Main Methods:

  • Retrospective analysis of DTI data from pediatric MS (n=18), monophasic illnesses (n=15), and controls.
  • DTI acquired within one month of symptom onset for monophasic cases and median 20 months for MS.
  • Semi-automated analysis of DTI measures (FA, AD, RD) in corpus callosum and internal capsule ROIs.

Main Results:

  • Pediatric MS group showed significantly lower fractional anisotropy (FA) and increased radial diffusivity (RD) compared to controls.
  • Monophasic group had lower FA and increased RD versus controls, but no difference in axial diffusivity (AD).
  • Pediatric MS group demonstrated reduced AD, a potentially novel finding.

Conclusions:

  • Normal-appearing white matter (NAWM) is affected in both pediatric MS and monophasic demyelinating disease.
  • Reduced axial diffusivity (AD) may be a distinguishing feature of pediatric MS.
  • Further studies are needed to validate DTI changes as biomarkers for pediatric demyelinating events.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Secondary Spinal Cord Injury llI: Pathophysiology01:25

Secondary Spinal Cord Injury llI: Pathophysiology

Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...
Alterations in Muscle Tone ll01:12

Alterations in Muscle Tone ll

Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...